Akers BioSciences Regains Compliance with Nasdaq Listing Standards
December 11, 2019 09:30 ET
|
Akers Biosciences Inc.
Thorofare, New Jersey, Dec. 11, 2019 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a developer of rapid health information technologies, announced today that on...
Akers BioSciences, Inc. Announces Closing of Approximately $8 Million Public Offering
December 09, 2019 11:40 ET
|
Akers Biosciences Inc.
Thorofare, New Jersey, Dec. 09, 2019 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company” or “we”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced the...
Akers Biosciences to Attend Hemp Industry Daily Forum in Las Vegas, Nevada
December 06, 2019 09:30 ET
|
Akers Biosciences Inc.
Thorofare, New Jersey, Dec. 06, 2019 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced that Executive...